STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction

For the popular diabetes and obesity medications known as GLP-1s, addiction medicine is one of many possible promising next acts. Eli Lilly is investigating a new drug, brenipatide, and testing it in alcohol use disorder. A new company called Baseline Therapeutics is studying a GLP-1 receptor agonist in alcohol, cocaine, and methamphetamine use disorders; Altimmune is testing one called pemvidutide for alcohol. Addiction medicine specialists are hopeful that the Food and Drug Administration may ...